These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31523821)

  • 41. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
    Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.
    Schulze V; Lin Y; Karathanos A; Brockmeyer M; Zeus T; Polzin A; Perings S; Kelm M; Wolff G
    Clin Res Cardiol; 2018 Sep; 107(9):745-755. PubMed ID: 29500568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of closure of patent foramen ovale in cryptogenic stroke: Current status.
    Abhishek BS; Bhambhani A
    Natl Med J India; 2017; 30(5):268-271. PubMed ID: 29916427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of patent foramen ovale in cryptogenic stroke.
    Budts W; Legrand V; Peeters A; Thijs V
    Acta Cardiol; 2012 Feb; 67(1):3-9. PubMed ID: 22455084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis.
    Vukadinović D; Schirmer SH; Vukadinović AN; Ukena C; Scheller B; Mahfoud F; Böhm M
    Clin Res Cardiol; 2019 Feb; 108(2):157-166. PubMed ID: 30051178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Closure of patent foramen ovale in cryptogenic stroke: a never ending story.
    Calvet D; Mas JL
    Curr Opin Neurol; 2014 Feb; 27(1):13-9. PubMed ID: 24300793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence.
    Mir H; Siemieniuk RAC; Ge L; Foroutan F; Fralick M; Syed T; Lopes LC; Kuijpers T; Mas JL; Vandvik PO; Agoritsas T; Guyatt GH
    BMJ Open; 2018 Jul; 8(7):e023761. PubMed ID: 30049703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brief history of patent foramen ovale and stroke.
    Furlan AJ
    Stroke; 2015 Feb; 46(2):e35-7. PubMed ID: 25586831
    [No Abstract]   [Full Text] [Related]  

  • 50. [Patent foramen ovale can cause cryptogenic stroke. Transcatheter closure as an alternative to medical therapy must be evaluated more].
    Ladenvall P; Dellborg M
    Lakartidningen; 2013 Sep 4-10; 110(36):1524-5. PubMed ID: 24163903
    [No Abstract]   [Full Text] [Related]  

  • 51. Patent foramen ovale and ischemic stroke recurrence: the end of a never-ending story?
    Tamayo A; Harrer JU
    Neurology; 2009 Jul; 73(2):84-5. PubMed ID: 19439718
    [No Abstract]   [Full Text] [Related]  

  • 52. [Patent foramen ovale - an unsuspected defect in the body].
    Nietlispach F
    Praxis (Bern 1994); 2016 Jan; 105(2):93-7. PubMed ID: 26787331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous patent foramen ovale occlusion: current evidence and evolving clinical practice.
    Leong MC; Uebing A; Gatzoulis MA
    Int J Cardiol; 2013 Nov; 169(4):238-43. PubMed ID: 24071386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Closure of the patent foramen ovale (PFO) in cryptogenic stroke].
    Diener HC; Knebel F
    Herz; 2019 Jun; 44(4):304-309. PubMed ID: 30941472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcatheter Closure of Patent Foramen Ovale: Randomized Trial Update.
    Arfaras-Melainis A; Palaiodimos L; Mojadidi MK
    Interv Cardiol Clin; 2019 Oct; 8(4):341-356. PubMed ID: 31445719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of patent foramen ovale in atrial fibrillation patients with history of cerebral ischemia: a stand-alone additional risk?
    Zoppo F; Stabile G; Pappone A; Avella A; Pecora D; Corò L; Zingarini G; Verlato R; Castro A; Bertaglia E
    Int J Cardiol; 2014 Mar; 172(2):e290-1. PubMed ID: 24444485
    [No Abstract]   [Full Text] [Related]  

  • 57. The best DEFENSE for high-risk patent foramen ovale: An updated meta-analysis of six randomized trials.
    Kokkinidis DG; Palaiodimos L; Mastoris I; Karamanis D; Faillace RT
    Arch Cardiovasc Dis; 2019 Mar; 112(3):150-152. PubMed ID: 30594572
    [No Abstract]   [Full Text] [Related]  

  • 58. Which Patent Foramen Ovales Need Closure to Prevent Cryptogenic Strokes?
    Dalen JE; Alpert JS
    Am J Med; 2018 Mar; 131(3):222-225. PubMed ID: 29175238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. When to close a patent foramen ovale.
    Kenny D; Turner M; Martin R
    Arch Dis Child; 2008 Mar; 93(3):255-9. PubMed ID: 17827196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patent foramen ovale and cryptogenic stroke in older patients.
    Handke M; Harloff A; Olschewski M; Hetzel A; Geibel A
    N Engl J Med; 2007 Nov; 357(22):2262-8. PubMed ID: 18046029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.